Kullberg BJ - Search Results

1

Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris.

Bruno M, Kersten S, Bain JM, Jaeger M, Rosati D, Kruppa MD, Lowman DW, Rice PJ, Graves B, Ma Z, Jiao YN, Chowdhary A, Renieris G, van de Veerdonk FL, Kullberg BJ, Giamarellos-Bourboulis EJ, Hoischen A, Gow NAR, Brown AJP, Meis JF, Williams DL, Netea MG. Bruno M, et al. Among authors: kullberg bj. Nat Microbiol. 2020 Dec;5(12):1516-1531. doi: 10.1038/s41564-020-0780-3. Epub 2020 Aug 24. Nat Microbiol. 2020. PMID: 32839538 Free PMC article.

2

[Yeast infections in patients with immunologic disorders].

van 't Wout JW, Kullberg BJ, Meis JF, Reiss P. van 't Wout JW, et al. Among authors: kullberg bj. Ned Tijdschr Geneeskd. 1995 Jul 15;139(28):1430-6. Ned Tijdschr Geneeskd. 1995. PMID: 7623929 Review. Dutch. No abstract available.

3

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice.

Netea MG, Blok WL, Kullberg BJ, Bemelmans M, Vogels MT, Buurman WA, van der Meer JW. Netea MG, et al. Among authors: kullberg bj. J Infect Dis. 1995 Feb;171(2):393-9. doi: 10.1093/infdis/171.2.393. J Infect Dis. 1995. PMID: 7844376 Free article.

4

Cytokines in the treatment of fungal infections.

Kullberg BJ, van 't Wout JW. Kullberg BJ, et al. Biotherapy. 1994;7(3-4):195-210. doi: 10.1007/BF01878486. Biotherapy. 1994. PMID: 7865351 Review.

5

An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy.

de Pauw BE, Raemaekers JM, Donnelly JP, Kullberg BJ, Meis JF. de Pauw BE, et al. Among authors: kullberg bj. Ann Hematol. 1995 Feb;70(2):83-7. doi: 10.1007/BF01834385. Ann Hematol. 1995. PMID: 7880929 Clinical Trial.

6

Severe osteomyelitis due to the zygomycete Apophysomyces elegans.

Meis JF, Kullberg BJ, Pruszczynski M, Veth RP. Meis JF, et al. Among authors: kullberg bj. J Clin Microbiol. 1994 Dec;32(12):3078-81. doi: 10.1128/jcm.32.12.3078-3081.1994. J Clin Microbiol. 1994. PMID: 7883908 Free PMC article. Review.

7

Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients.

Verweij PE, Donnelly JP, Kullberg BJ, Meis JF, De Pauw BE. Verweij PE, et al. Among authors: kullberg bj. Infection. 1994 Mar-Apr;22(2):81-5. doi: 10.1007/BF01739009. Infection. 1994. PMID: 8070935 Clinical Trial.

8

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Netea MG, Demacker PN, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AF, van der Meer JW. Netea MG, et al. Among authors: kullberg bj. J Clin Invest. 1996 Mar 15;97(6):1366-72. doi: 10.1172/JCI118556. J Clin Invest. 1996. PMID: 8617867 Free PMC article.

9

Helicobacter cinaedi bacteremia associated with localized pain but not with cellulitis.

van der Ven AJ, Kullberg BJ, Vandamme P, Meis JF. van der Ven AJ, et al. Among authors: kullberg bj. Clin Infect Dis. 1996 Apr;22(4):710-11. doi: 10.1093/clinids/22.4.710. Clin Infect Dis. 1996. PMID: 8729212 Free article. No abstract available.

10

The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice.

Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. Netea MG, et al. Among authors: kullberg bj. Blood. 1997 Jan 15;89(2):577-82. Blood. 1997. PMID: 9002961 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

427 results

Search Page